Literature DB >> 26906622

Essential role of STX6 in esophageal squamous cell carcinoma growth and migration.

Jin Du1, Xiang Liu2, Yanhu Wu3, Jinfu Zhu2, Yihu Tang2.   

Abstract

Abnormalities in endosomes, or dysregulation in their trafficking, play an important role directly in many diseases including oncogenesis. Syntaxin-6 (STX6) is involved in diverse cellular functions in a variety of cell types and has been shown to regulate many intracellular membrane trafficking events such as endocytosis, recycling and anterograde and retrograde trafficking. However, its expression pattern and biological functions in esophageal squamous cell carcinoma (ESCC) remained unknown. Here, we have found that the expression of STX6 was up-regulated in ESCC samples, its expression was significantly correlated with tumor size, histological differentiation, lymph node metastasis and depth. On one hand, STX6 silencing inhibited ESCC cells viability and proliferation in a p53-dependent manner. On the other hand, STX6 effect integrin trafficking and regulate ESCC cells migration. Taken together, our study revealed the oncogenic roles of STX6 in the progression of ESCC, and it might be a valuable target for ESCC therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell growth and migration; ESCC; Integrin trafficking; STX6; p53

Mesh:

Substances:

Year:  2016        PMID: 26906622     DOI: 10.1016/j.bbrc.2016.02.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer.

Authors:  Joseph M Luna; Juan M Barajas; Kun-Yu Teng; Hui-Lung Sun; Michael J Moore; Charles M Rice; Robert B Darnell; Kalpana Ghoshal
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

Review 2.  Annexin A6-A multifunctional scaffold in cell motility.

Authors:  Thomas Grewal; Monira Hoque; James R W Conway; Meritxell Reverter; Mohamed Wahba; Syed S Beevi; Paul Timpson; Carlos Enrich; Carles Rentero
Journal:  Cell Adh Migr       Date:  2017-01-06       Impact factor: 3.405

3.  Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer.

Authors:  Alexander Schramm; Martin Schuler; Clotilde Thumser-Henner; Sebastian Oeck; Sophie Kalmbach; Jan Forster; Franziska Kindl; Ali Sak
Journal:  Cell Death Dis       Date:  2022-06-06       Impact factor: 9.685

4.  Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.

Authors:  Taylor C Peak; Gati K Panigrahi; Prakash P Praharaj; Yixin Su; Lihong Shi; Jacqueline Chyr; José Rivera-Chávez; Laura Flores-Bocanegra; Ravi Singh; Donald J Vander Griend; Nicholas H Oberlies; Bethany A Kerr; Ashok Hemal; Rhonda L Bitting; Gagan Deep
Journal:  Mol Carcinog       Date:  2019-11-01       Impact factor: 4.784

5.  Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression.

Authors:  Zhaoan Lu; Chuanwen Wang; Xiaolong Lv; Wen Dai
Journal:  J Bone Oncol       Date:  2021-04-22       Impact factor: 4.072

6.  Role of STX6 as a prognostic factor associated with immune infiltration in hepatocellular carcinoma.

Authors:  Yang Zhang; Leyan Li; Yi Tu; Zongfeng Feng; Yong Li; Jianbo Xiong
Journal:  Oncol Lett       Date:  2022-09-05       Impact factor: 3.111

7.  Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition.

Authors:  Cristiana Perrotta; Davide Cervia; Ilaria Di Renzo; Claudia Moscheni; Maria Teresa Bassi; Lara Campana; Cristina Martelli; Elisabetta Catalani; Matteo Giovarelli; Silvia Zecchini; Marco Coazzoli; Annalisa Capobianco; Luisa Ottobrini; Giovanni Lucignani; Patrizia Rosa; Patrizia Rovere-Querini; Clara De Palma; Emilio Clementi
Journal:  Front Immunol       Date:  2018-05-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.